Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
SAN DIEGO, July 19, 2016 -- Access Scientific has introduced the POWERWAND™ XL, a companion to the POWERWAND ALL-IN-ONE. The new POWERWAND XL is designed specifically for clinicians who prefer to use a component-based, over-wire insertion technique similar to the Modified Seldinger Technique (MST) they currently use. The XL technique feels similar to the MST but has these distinct advantages:
- Improves clinical outcomes through atraumatic catheter insertion
- Designed to reduce risk of deep-vein thrombosis by up to 500%; no trimming of catheter necessary
- Reduces risk of back leaking; no peel-away sheath
- Guidewire extends fully so the catheter does not drag across the intima of the vessel
- Faster and safer because of fewer steps (see table below).
|
||||||||||
As with MST insertions, the XL insertion technique utilizes a 21-gauge safety needle and guidewire to access the vessel. The XL accelerates line placement and makes it safer compared to MST, by eliminating the need for a peelable introducer sheath. Instead, the proprietary POWERWAND XL dilator and catheter are inserted directly over the wire and into the bloodstream. This technique eliminates the sheath-related steps in MST that can be associated with such risks as bleeding, back-leaking, and vessel damage.
The ALL-IN-ONE is inserted with the Accelerated Seldinger Technique (AST), which also improves on the MST in speed, number of steps, and safety (see table below). Both ALL-IN-ONE and XL deliver the evidence based, best in class midline:
- Size: 4Fr and 5Fr
- Length: 8 and 10cm
- Infection Prevention: ZERO BSIs over 12,000 catheter-days
- High Flow: Capable of delivering large volumes rapidly, 130-180 ml/min
- Power Injectable: 325psi / 8ml per second
- Blood Drawable: Allows for blood draws in most patients, 60 – 99%
- Patient Satisfaction: Provides patients with one stick hospitalization
Insertion Technique Comparison: MST, AST, and XL
[table #1]
About Access Scientific, LLC
Access Scientific is dedicated to the development and commercialization of breakthrough, proprietary devices that make vascular access safer for patients and reduce the cost of care. The company pioneered the power-injectable midline market with the POWERWAND™. Made of proprietary ChronoFlex™ C, the POWERWAND midline has been the proven, evidence based, best-in-class, with over 12,000 catheter-days of published scientific data attesting to the lowest complication rate and highest completion-of-therapy rate of any vascular access device ever studied. The POWERWAND offers a unique approach to reducing hospital-acquired infections.
Photos accompanying this release are available at:
http://www.globenewswire.com/newsroom/prs/?pkgid=40876
http://www.globenewswire.com/newsroom/prs/?pkgid=40877
CONTACT: Liz Dowling, (415) 388-2794
Dowling & Dennis Public Relations
E-mail: [email protected]
